Compare AJANTA PHARMA with ALEMBIC - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AJANTA PHARMA vs ALEMBIC - Comparison Results

ALEMBIC 
   Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AJANTA PHARMA ALEMBIC AJANTA PHARMA/
ALEMBIC
 
P/E (TTM) x 24.4 62.6 38.9% View Chart
P/BV x 6.8 5.4 125.4% View Chart
Dividend Yield % 0.5 0.2 275.6%  

Financials

 AJANTA PHARMA   ALEMBIC
EQUITY SHARE DATA
    AJANTA PHARMA
Mar-19
ALEMBIC
Mar-18
AJANTA PHARMA/
ALEMBIC
5-Yr Chart
Click to enlarge
High Rs1,42272 1,974.9%   
Low Rs89834 2,647.8%   
Sales per share (Unadj.) Rs233.54.7 4,967.7%  
Earnings per share (Unadj.) Rs44.06.1 720.3%  
Cash flow per share (Unadj.) Rs52.26.2 835.1%  
Dividends per share (Unadj.) Rs9.000.20 4,500.0%  
Dividend yield (eoy) %0.80.4 205.5%  
Book value per share (Unadj.) Rs255.140.7 627.3%  
Shares outstanding (eoy) m88.02267.03 33.0%   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x5.011.3 44.1%   
Avg P/E ratio x26.48.7 304.1%  
P/CF ratio (eoy) x22.28.5 262.3%  
Price / Book Value ratio x4.51.3 349.1%  
Dividend payout %20.53.3 624.7%   
Avg Mkt Cap Rs m102,08114,139 722.0%   
No. of employees `0006.8NA-   
Total wages/salary Rs m4,307207 2,076.7%   
Avg. sales/employee Rs Th3,022.6NM-  
Avg. wages/employee Rs Th633.4NM-  
Avg. net profit/employee Rs Th569.1NM-  
INCOME DATA
Net Sales Rs m20,5541,255 1,637.5%  
Other income Rs m211370 56.9%   
Total revenues Rs m20,7651,625 1,277.5%   
Gross profit Rs m5,664111 5,098.4%  
Depreciation Rs m72138 1,906.9%   
Interest Rs m122 682.4%   
Profit before tax Rs m5,143442 1,164.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m01,212 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,27324 5,315.2%   
Profit after tax Rs m3,8701,630 237.4%  
Gross profit margin %27.68.9 311.4%  
Effective tax rate %24.85.4 456.6%   
Net profit margin %18.8129.8 14.5%  
BALANCE SHEET DATA
Current assets Rs m11,8121,867 632.7%   
Current liabilities Rs m3,776591 638.8%   
Net working cap to sales %39.1101.6 38.5%  
Current ratio x3.13.2 99.0%  
Inventory Days Days7794 82.1%  
Debtors Days Days8274 111.0%  
Net fixed assets Rs m14,3981,791 804.0%   
Share capital Rs m175534 32.8%   
"Free" reserves Rs m22,27710,324 215.8%   
Net worth Rs m22,45210,858 206.8%   
Long term debt Rs m741 16.0%   
Total assets Rs m26,96211,591 232.6%  
Interest coverage x444.3260.9 170.3%   
Debt to equity ratio x00 7.7%  
Sales to assets ratio x0.80.1 703.9%   
Return on assets %14.414.1 102.3%  
Return on equity %17.215.0 114.8%  
Return on capital %23.015.2 151.1%  
Exports to sales %01.5 0.0%   
Imports to sales %021.0 0.0%   
Exports (fob) Rs mNA19 0.0%   
Imports (cif) Rs mNA263 0.0%   
Fx inflow Rs m10,68219 55,060.3%   
Fx outflow Rs m2,102264 796.7%   
Net fx Rs m8,580-244 -3,510.3%   
CASH FLOW
From Operations Rs m3,748236 1,589.4%  
From Investments Rs m-2,228-224 994.6%  
From Financial Activity Rs m-1,475-27 5,543.6%  
Net Cashflow Rs m45-15 -305.4%  

Share Holding

Indian Promoters % 73.8 64.0 115.3%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 1.6 0.2 775.0%  
FIIs % 7.6 9.7 78.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.0 26.1 65.1%  
Shareholders   20,968 54,701 38.3%  
Pledged promoter(s) holding % 4.4 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AJANTA PHARMA With:   PIRAMAL ENTERPRISES  NOVARTIS  DR. DATSONS LABS  DR. REDDYS LAB  GSK PHARMA  

Compare AJANTA PHARMA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 154 Points Lower, Nifty Ends at 14,834; Bajaj Finance and UPL Among Top Losers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended marginally lower.

Related Views on News

AJANTA PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 64.2% (Quarterly Result Update)

Feb 5, 2021 | Updated on Feb 5, 2021

For the quarter ended December 2020, AJANTA PHARMA has posted a net profit of Rs 2 bn (up 64.2% YoY). Sales on the other hand came in at Rs 7 bn (up 15.0% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

AJANTA PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 46.3% (Quarterly Result Update)

Nov 6, 2020 | Updated on Nov 6, 2020

For the quarter ended September 2020, AJANTA PHARMA has posted a net profit of Rs 2 bn (up 46.3% YoY). Sales on the other hand came in at Rs 7 bn (up 11.4% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

AJANTA PHARMA Announces Quarterly Results (1QFY21); Net Profit Up 28.9% (Quarterly Result Update)

Aug 24, 2020 | Updated on Aug 24, 2020

For the quarter ended June 2020, AJANTA PHARMA has posted a net profit of Rs 1 bn (up 28.9% YoY). Sales on the other hand came in at Rs 7 bn (up 9.2% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

ALEMBIC LTD Announces Quarterly Results (1QFY21); Net Profit Up 3.5% (Quarterly Result Update)

Aug 10, 2020 | Updated on Aug 10, 2020

For the quarter ended June 2020, ALEMBIC LTD has posted a net profit of Rs 21 m (up 3.5% YoY). Sales on the other hand came in at Rs 131 m (down 49.7% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

AJANTA PHARMA Announces Quarterly Results (4QFY20); Net Profit Up 45.3% (Quarterly Result Update)

May 21, 2020 | Updated on May 21, 2020

For the quarter ended March 2020, AJANTA PHARMA has posted a net profit of Rs 1 bn (up 45.3% YoY). Sales on the other hand came in at Rs 7 bn (up 32.4% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

More Views on News

Most Popular

A Critical Update on the Market(Fast Profits Daily)

Mar 30, 2021

In this video, I'll tell you why I am recommending caution in the market at this time.

My Recent Recommendation Will Profit from the Global Supply Chain Crisis(Profit Hunter)

Mar 31, 2021

A tiny chemical company, started in the Licence Raj era, is a great example of a new wealth creating opportunity.

My Stock Trading Strategy(Fast Profits Daily)

Mar 31, 2021

In this video I'll show you exactly how I go about picking stocks for trading.

What You Need to Find Hundred Baggers(Profit Hunter)

Mar 30, 2021

100 baggers of the last decade share this common trait. Here's how to use it to nail future multibaggers.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

AJANTA PHARMA SHARE PRICE


Apr 9, 2021 (Close)

TRACK AJANTA PHARMA

  • Track your investment in AJANTA PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

AJANTA PHARMA 5-YR ANALYSIS

COMPARE AJANTA PHARMA WITH

MARKET STATS